Evidence map›Paper›PMID 40538019›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2025

Extension and external validation of mapping between the Mini-Mental State Examination and the Clinical Dementia Rating scale in patients with Alzheimer's disease.

Niels Juul Brogaard, Julie Hviid Hahn-Pedersen, Jens Gundgaard, Pepa Polavieja, Benjamin D Bray, Mei Sum Chan, Men Hoang, Dominic Trepel

Abstract readValidation Study
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Niels Juul BrogaardNovo Nordisk A/S, Søborg, Denmark.
Julie Hviid Hahn-PedersenNovo Nordisk A/S, Søborg, Denmark.
Jens GundgaardNovo Nordisk A/S, Søborg, Denmark.
Pepa PolaviejaNovo Nordisk A/S, Søborg, Denmark.
Benjamin D BrayHealth Analytics, Lane Clark & Peacock LLP, London, UK.
Mei Sum ChanHealth Analytics, Lane Clark & Peacock LLP, London, UK.
Men HoangDepartment of Psychiatry, School of Medicine, Trinity College Dublin, Dublin, Ireland.
Dominic TrepelDepartment of Psychiatry, School of Medicine, Trinity College Dublin, Dublin, Ireland.ORCID 0000-0002-1421-2966

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionWe aimed to develop and externally validate a mapping to translate Mini-Mental State Examination (MMSE) scores to Clinical Dementia Rating scale Sum of Boxes (CDR-SB) scores in patients with Alzheimer's disease (AD).

methodsWe extended a previously published CDR-SB to MMSE mapping to include later stages of AD and validated it using the US National Alzheimer's Coordinating Centers (NACC) database. Calibration and discrimination metrics were evaluated, and the mapping was validated in clinically relevant subgroups of the AD population.

resultsA linear MMSE to CDR-SB mapping ( DISCUSSION: This MMSE to CDR-SB MMSE mapping performed generally well though caution is needed when applying this mapping to people with severe AD dementia. It could be used to help contextualize outcomes in AD clinical trials and real-world health research studies. HIGHLIGHTS: We developed a mapping between the CDR-SB and MMSE instruments, by obtaining the optimal functional form of a mapping previously published using data from the Alzheimer's Disease Neuroimaging Initiative dataset and extending it to the full range of clinical severities for Alzheimer's disease. The resulting mapping was externally validated using 26,729 MMSE and CDR-SB pairs from participants recruited to the US National Alzheimer's Coordinating Centers database. The selected model satisfied the pre-specified selection criteria and the extended mapping demonstrated good performance, especially in the earlier clinical stages. However, caution is advised when inferring mapped scores in more severe dementia. The extension and subsequent validation of the mapping can support the translation of AD severity assessments between datasets using CDR-SB and MMSE, bridging a common information gap between clinical trials, real-world evidence studies, and clinical practice.

Indexed as

Alzheimer DiseaseMental Status and Dementia TestsAgedAged, 80 and overFemaleHumansMaleNeuropsychological TestsReproducibility of ResultsClinical Dementia Rating scale Sum of Boxescognitive assessment mappingexternal validationMini‐Mental State Examination

Identifiers

PMID40538019
PMCPMC12179331

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.